Spots Global Cancer Trial Database for malignant melanoma of skin stage iv
Every month we try and update this database with for malignant melanoma of skin stage iv cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Vaccination With Autologous Dendritic Cells Loaded With Autologous Tumor Lysate or Homogenate Combined With Immunomodulating Radiotherapy and/or Preleukapheresis IFN-alfa in Patients With Metastatic Melanoma: a Randomized "Proof-of-principle" Phase II Study | NCT01973322 | Malignant Melan... Malignant Melan... | arm 1: DC Vacci... arm 2: DC Vacci... arm 3: both arm... arm 4: DC Vacci... | 18 Years - 70 Years | Istituto Scientifico Romagnolo per lo Studio e la cura dei Tumori | |
Vaccination With Autologous Dendritic Cells Loaded With Autologous Tumor Lysate or Homogenate Combined With Immunomodulating Radiotherapy and/or Preleukapheresis IFN-alfa in Patients With Metastatic Melanoma: a Randomized "Proof-of-principle" Phase II Study | NCT01973322 | Malignant Melan... Malignant Melan... | arm 1: DC Vacci... arm 2: DC Vacci... arm 3: both arm... arm 4: DC Vacci... | 18 Years - 70 Years | Istituto Scientifico Romagnolo per lo Studio e la cura dei Tumori | |
Vaccination With Autologous Dendritic Cells Loaded With Autologous Tumor Lysate or Homogenate Combined With Immunomodulating Radiotherapy and/or Preleukapheresis IFN-alfa in Patients With Metastatic Melanoma: a Randomized "Proof-of-principle" Phase II Study | NCT01973322 | Malignant Melan... Malignant Melan... | arm 1: DC Vacci... arm 2: DC Vacci... arm 3: both arm... arm 4: DC Vacci... | 18 Years - 70 Years | Istituto Scientifico Romagnolo per lo Studio e la cura dei Tumori |